Lv2
130 积分 2023-04-30 加入
Exploration of Bicyclic Peptide Ligands for Immune-Specific PET Imaging: Targeting Tumor PD-L1 with [18F]AlF-BCY10959
1天前
已完结
Development of a 18F-Labeled Bicyclic Peptide Targeting EphA2 for Molecular Imaging of PSMA-Negative Prostate Cancer
1天前
已完结
First-in-Human Study of the Radioligand 68Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma
1天前
已完结
Nanobody-based targeted cancer therapy and immunotherapy: fear not the future
1天前
已完结
Evaluation of novel anti-CEACAM6 antibody-based conjugates for radioimmunotheranostics of pancreatic ductal adenocarcinoma
4天前
已完结
Preclinical Development and Comparison of [ 99m Tc]Tc/[ 177 Lu]Lu-Labeled Anti-Trop2 Fc-Fused Nanobodies as Pancreatic Cancer Theranostics
4天前
已完结
The role of radiotheranostics in personalized treatment for breast cancer
4天前
已完结
Theranostics targeting fibroblast activation protein in the pan‐cancer field
5天前
已完结
Rational Design and Pharmacomodulation of Protein-Binding Theranostic Radioligands for Targeting the Fibroblast Activation Protein
5天前
已完结
Unveiling the molecular and immunological drivers of antibody–drug conjugates in cancer treatment
7天前
已完结
皖公网安备34019202002308
